- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03594279
Community Mobilization and Incentivization for Childhood Diarrhea and Pneumonia (CoMIC)
Evaluation of a Community Engagement and Demand Creation Strategy for Childhood Diarrhea and Pneumonia in Pakistan
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Components and Objectives:
This study will be conducted in two phases:
- Formative phase: The objective of this phase is to assess the existing care seeking practices and care provision for childhood diarrhea and pneumonia and identify the existing barriers and facilitators for care seeking for childhood diarrhea and pneumonia.
- Cluster Randomized Trial: (CoMIC Trial - Community Mobilization and Community Incentivization): The objective of this phase is to assess the impact of a community engagement and demand creation strategy involving an community-based incentive scheme on adherence to recommended preventive and curative practices for diarrhea and pneumonia among children under five years of age.
Study site: This study will be conducted in Tando Muhammad Khan, which is a rural district in the province of Sindh. This would a three and half year study with two year of intervention period.
Study design: This study will follow a mixed methodology approach with a formative research component followed by a prospective two arm cluster randomized controlled trial (cRCT).
Formative Phase: The following activities will be conducted in the formative phase:
- GIS Mapping: for the whole district to map all the government health facilities, schools, major religious places (mosques), water supply sources and roads.
- Qualitative research: comprising of focus group discussion (FGDs) and in-depth interviews (IDIs) with all stakeholders. These would also identify the potential non-cash incentives that the community wants and could be attractive
- Baseline Household Survey: Baseline survey will be conducted at the household level and will gather information on health care practices pertaining to childhood diarrhea and pneumonia, immunization, socio-economic indicators, childhood nutrition indicators and WASH indicators. LHWs working in the study area and their geographic spread will also be identified.
Randomized Controlled Trial:
-Randomization: After the mapping and formative research, the clusters (villages) will be randomly allocated to two intervention arms and a control arm by an independent statistician in the ratio of 1:1:1.
Sample size: The sample size was calculated with a power of 0.8 and alpha of 0.05 giving 14 clusters per arm (maximum sample size). These clusters will be randomly allocated to three arms.
Intervention:
Arm 1: In Arm 1, separate male and female village committees (VC) consisting of prominent members of the community including local elites/leaders (6 to 8 in a group) in all the villages will be formed and they would be trained on specific messages regarding the prevention and management of childhood diarrhea and pneumonia. The VCs would carry out awareness and motivational activities for the uptake of the identified interventions. They would also facilitate two hour group meetings to be held twice every month in every village of their catchment area and focus on issues pertaining to childhood nutrition, WASH, vaccines and management of diarrhea and pneumonia in children. Apart from these, there would researcher led awareness sessions in this intervention cluster and specific sessions for children would also be conducted. These sessions would focus on providing education and encourage community participation. Group activities would also identify community level health, nutrition and sanitation problems, and to find locally feasible strategies to address them.
Arm 2: In the second intervention cluster; in addition to the interventions in Arm 1, the areas which improve the practices for preventive and curative strategies for diarrhea and pneumonia will receive community-based incentive. This would be a unique incentive scheme as all the previous financial incentive programs whether conditional or unconditional cash transfers, voucher schemes, social insurance schemes have targeted individuals and all these incentives were based on improving individual practices. The financial incentive proposed is unique as this initiative which would benefit the community as a whole and incentives based on improvement in the composite coverage of three indicators:
- Age-appropriate immunization 12-23 months
- ORS use for diarrhea
- Sanitation index (which is a score based on personal, household and environmental hygiene) The incentives would include structural benefits linked to health including tube wells, water supply, toilets in community/schools, water storage facility or any other incentive as decided with the respective village committees. The total cost of these incentives would be shared by the project (75%) and the community (25%), to improve ownership. The contribution from the community could also be in-kind including labor etc.
Arm 3: This arm will receive routine standard of care.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Sindh
-
Karachi, Sindh, Pakistan, 74800
- Aga Khan University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- People residing in the villages in the selected study site and consent to participate.
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Community Mobilization
This arm will receive specific messages regarding the prevention and management of childhood diarrhea and pneumonia.
The investigators will form village committees (VC) consisting of prominent members of the community (6-8 in a group) to carry out awareness and motivational activities for the uptake of the identified interventions.
|
Community Mobilization
Community Mobilization and Community Incentive
|
Experimental: Community Mobilization and Community Incentive
In this arm, along with the interventions in the community mobilization arm, community based incentives will also be provided.
The clusters which improve the practices for preventive and curative strategies for diarrhea and pneumonia will receive community-based incentive including structural benefits linked to health including tube wells, water supply, toilets in community/schools, water storage facility or any other incentive as decided with the respective village committees.
|
Community Mobilization and Community Incentive
|
No Intervention: Control
This arm will receive the routine standard of care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Age-appropriate immunization 12-23 months
Time Frame: At six months of intervention
|
At six months of intervention
|
|
ORS use for diarrhea
Time Frame: At six months of intervention
|
At six months of intervention
|
|
Mean Sanitation Index
Time Frame: At six months of intervention
|
The scale is focused on 12 components. All the components are valued equally and can be scored '0' (for 'No') or '1' (for 'Yes'). These would be summed up for each household for a total possible score of 12 and a range of 0-12. Higher score represents a better outcome. It comprises of the following three subscales:
|
At six months of intervention
|
Age-appropriate immunization 12-23 months
Time Frame: At 12 months of intervention
|
At 12 months of intervention
|
|
ORS use for diarrhea
Time Frame: At 12 months of intervention
|
At 12 months of intervention
|
|
Mean Sanitation Index
Time Frame: At 12 months of intervention
|
The scale is focused on 12 components. All the components are valued equally and can be scored '0' (for 'No') or '1' (for 'Yes'). These would be summed up for each household for a total possible score of 12 and a range of 0-12. Higher score represents a better outcome. It comprises of the following three subscales:
|
At 12 months of intervention
|
Age-appropriate immunization 12-23 months
Time Frame: At 24 months of intervention
|
At 24 months of intervention
|
|
ORS use for diarrhea
Time Frame: At 24 months of intervention
|
At 24 months of intervention
|
|
Mean Sanitation Index
Time Frame: At 24 months of intervention
|
The scale is focused on 12 components. All the components are valued equally and can be scored '0' (for 'No') or '1' (for 'Yes'). These would be summed up for each household for a total possible score of 12 and a range of 0-12. Higher score represents a better outcome. It comprises of the following three subscales:
|
At 24 months of intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Handwashing with soap at important time
Time Frame: At 24 months of intervention
|
At 24 months of intervention
|
Exclusive breastfeeding rates - children who are exclusively breastfed at 6 months of age
Time Frame: At 24 months of intervention
|
At 24 months of intervention
|
Care seeking for severe cases of childhood diarrhea and pneumonia - parents/caregivers who sought care for child with diarrhea/pneumonia
Time Frame: At 24 months of intervention
|
At 24 months of intervention
|
Prevalence of Diarrhea and pneumonia
Time Frame: At 24 months of intervention
|
At 24 months of intervention
|
Open defecation rates
Time Frame: At 24 months of intervention
|
At 24 months of intervention
|
Total cost (unit cost and cost effectiveness)
Time Frame: At 24 months of intervention
|
At 24 months of intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4676-WCH-ERC-17
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Diarrhea
-
International Centre for Diarrhoeal Disease Research...Completed
-
Duke UniversityUniversity College, London; Stanford University; Sambodhi Research and Communication... and other collaboratorsCompletedDiarrhea, Infantile | Childhood PneumoniaIndia
-
Johns Hopkins UniversityNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Diarrhea | Gastrointestinal ComplicationsUnited States
-
Aboca Spa Societa' AgricolaUnknownDiarrhea | Diarrhea, Infantile | Chronic Diarrhea | Acute Diarrhea
-
Napo Pharmaceuticals, Inc.Active, not recruitingAdult Solid Tumor | Cancer Therapy-Related Diarrhea | Chemotherapy-related Diarrhea | Prophylaxis of Diarrhea | Symptomatic Relief of Diarrhea | Targeted Therapy-related DiarrheaUnited States, Taiwan, Georgia, Serbia, Argentina
-
South Shore HospitalWithdrawnAntibiotic Associated Diarrhea | Clostridium Difficile Associated Diarrhea
-
Hospital San BartolomeInstituto de Investigacion de las Alteraciones del Crecimiento, Desarrollo...Unknown
-
Cosmo Technologies LtdBausch Health Americas, Inc.CompletedTraveler's DiarrheaGuatemala, Mexico
-
Sana'a UniversityCompleted
-
PATHUniversity of Maryland; Center for Vaccine Development - MaliCompleted
Clinical Trials on Community Mobilization
-
University of North Carolina, Chapel HillCompletedHIV InfectionUnited States
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaboratorsCompleted
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute of Mental Health...Completed
-
University of California, San FranciscoUniversity of North Carolina, Chapel Hill; University of Witwatersrand, South...Completed
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Funmilola OlaOlorunUniversity of IbadanCompletedDomestic Violence | Violence | AttitudeNigeria
-
University of North Carolina, Chapel HillUniversity of California, San Francisco; University of Witwatersrand, South...CompletedGender RelationsSouth Africa
-
Aga Khan UniversityCompletedPolio | Incentives | Immunization; InfectionPakistan
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Mental Health (NIMH); TB/HIV Care; Community Media TrustCompletedHIV Infections | Pre-exposure ProphylaxisSouth Africa